从鼓动性胸部CT估计小气管疾病的深度学习与FEV相关1 慢性肺炎的减少
Muhammad F A Chaudhary1,2, Hira A Awan1, Sarah E Gerard1
1The Roy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, IA, 52242.
medRxiv : the preprint server for health sciences
|September 24, 2024
概括
人工智能现在可以使用全肺容量 (TLC) CT 扫描来量化功能性小气道疾病 (fSAD). 这种AI衍生的fSADTLC是可靠的,并且与COPD患者的疾病进展有关.
科学领域:
- 肺部医学 肺部医学
- 放射学 放射学是一门学科.
- 人工智能在医学中的应用
背景情况:
- 量化功能性小气道疾病 (fSAD) 通常需要额外的呼吸道CT扫描,限制其临床使用.
- 人工智能 (AI) 提供了一个潜在的解决方案,通过在全肺容量 (TLC) 的单个启发性CT扫描中实现fSAD量化,称为fSADTLC.
研究的目的:
- 评估一个AI模型来估计fSADTLC.
- 在慢性阻塞性肺病 (COPD) 患者中研究fSADTLC的临床关联.
主要方法:
- 在SPIROMICS研究中,使用1055名COPD参与者的CT扫描开发了一个生成AI模型,以估计fSADTLC.
- 人工智能模型应用于1458名SPIROMICS参与者,并在COPDGene研究中的458名参与者中得到验证.
- fSADTLC与双体积,参数响应映射fSADPRM进行了比较,并分析了其与肺功能 (FEV1,FEV1/FVC),6MWD,SGRQ和FEV1的相关性.
主要成果:
- 在SPIROMICS (R=0.895) 和COPDGene (R=0.897) 队列中,fSADTLC与fSADPRM具有很高的相关性.
- 在这两组研究中,fSADTLC与FEV1,FEV1/FVC,SGRQ得分以及FEV1的下降有显著的关联.
- 与fSADPRM (ICC=0.83) 相比,AI衍生的fSADTLC显示出更高的重复性 (ICC=0.99).
结论:
- 基于AI的fSADTLC量化来自启发性CT扫描是评估小气道疾病的可靠方法.
- fSADTLC是临床相关的,显示了与COPD严重程度和进展的显著关联.
- 这种人工智能方法简化了fSAD评估,潜在地提高了临床适用性和患者管理.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
243
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
243
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
186
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
186


